Abstract
Vascular endothelial growth factor-C (VEGF-C) functions specifically to induce lymphangiogenesis. We examined the relationship between expression of VEGF-C and clinicopathological features in patients with colorectal cancer. The expression of VEGF-C in the 99 primary tumours and 18 metastatic lymph nodes from colorectal cancer patients was examined immunohistochemically. To verify VEGF-C mRNA expression, reverse transcriptase-polymerase chain reaction (RT-PCR) was carried out. The expression of VEGF-C correlated with lymphatic involvement, lymph nodes metastasis, and depth of invasion. On the other hand, correlations were nil with regard to gender of the patients, histologic type, venous involvement, and liver metastasis. The expression of VEGF-C in metastatic lymph nodes was fairly consistent with this expression in the primary tumour. Survival time was shorter for VEGF-C positive groups than for VEGF-C negative ones, but with no statistically significant difference. RT-PCR findings revealed that the expression of VEGF-C mRNA correlated mostly with that of VEGF-C protein expression. VEGF-C may play an important role in lymphatic spread of colorectal cancer. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT, Smyth E and Colquhoun K (1985) A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 72: 698–702
Dukes CE and Bussey HJR (1958) The spread of rectal cancer and its effect on prognosis. Br J Cancer 12: 309–320
Ferrara N and Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18: 4–25
Fielding LP, Phillips RK, Fry JS and Hittinger R (1986) Prediction of outcome after curative resection for large bowel cancer. Lancet 2: 904–907
Hermanek P (1995) pTNM and residual tumor classifications: problems of assessment and prognostic significance. World J Surg 19: 184–190
Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK and Alitalo K (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423–1425
Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N and Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15: 1751
Joukov V, Kaipainen A, Jeltsch M, Pajusola K, Olofsson B, Kumar V, Eriksson U and Alitalo K (1997) Vascular endothelial growth factors VEGF-B and VEGF-C. J Cell Physiol 173: 211–215
Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, Breitman M and Alitalo K (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92: 3566–3570
Kitadai Y, Haruma K, Tokutomi T, Tanaka S, Sumii K, Carvalho M, Kuwabara M, Yoshida K, Hirai T, Kajiyama G and Tahara E (1998) Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clinical Cancer Research 4: 2195–2200
Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V and Alitalo K (1996) VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122: 3829–3837
Landgren E, Schiller P, Cao Y and Claesson-Welsh L (1998) Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Oncogene 16: 359–367
Newland RC, Chapuis PH, Pheils MT and MacPherson JG (1981) The relationship of survival to staging and grading of colorectal carcinoma: a prospective study of 503 cases. Cancer 47: 1424–1429
Ohta Y, Shridha V, Bright RK, Kalemkerian GP, Du W, Carbone M, Watanabe Y and Pass HI (1999) VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br J Cancer 81, 1 54–61
Paavonen K, Horelli-Kuitunen N, Chilov D, Kukk E, Pennanen S, Kallioniemi OP, Pajusola K, Olofsson B, Eriksson U, Joukov V, Palotie A and Alitalo K (1996) Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively. Circulation 93: 1079–1082
Partanen TA, Alitalo K and Miettinen M (1999) Lack of lymphatic vascular specificity of vascular endothelial gorwth factor receptor 3 in 185 vascular tumors. Cancer 86: 2406–2412
Salven P, Lymboussaki A, Heikkila P, Jaaskela-Saari H, Enholm B, Aase K, von Euler G, Eriksson U, Alitalo K and Joensuu H (1998) Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 153: 103–108
Scheele J, Stangl R and Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77: 1241–1246
Sobin LH and Wittekind C (1997) TNM classification of malignant tumours. International Union Against Cancer, 66–73
Sugihara K, Hojo K, Moriya Y, Yamasaki S, Kosuge T and Takayama T (1993) Pattern of recurrence after hepatic resection for colorectal metastases. Br J Surg 80: 1032–1035
Tomisaki S, Ohno S, Ichiyoshi Y, Kuwano H, Maehara Y and Sugimachi K (1996) Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer 77: 1722–1728
Tsuchiya A, Ando Y, Kikuchi Y, Kanazawa M, Sato H and Abe R (1995) Venous invasion as a prognostic factor in colorectal cancer. Surg Today 25: 950–953
Tsurusaki T, Kanda S, Sakai H, Kanetake H, Saito Y, Alitalo K and Koji T (1999) Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 80: 309–313
Valtola R, Salven P, Heikkila P, Taipale J, Joensuu H, Rehn M, Pihlajaniemi T, Weich H, de Waal R and Alitalo K (1999) VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 154: 1381–1390
Wartiovaara U, Salven P, Mikkola H, Lassila R, Kaukonen J, Joukov V, Orpana A, Ristimaki A, Heikinheimo M, Joensuu H, Alitalo K and Palotie A (1998) Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 80: 171–175
Yonemura Y, Endo Y, Fujita H, Fushida S, Ninomiya I, Bandou E, Taniguchi K, Miwa K, Ohoyama S, Sugiyama K and Sasaki T (1999) Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 5: 1823–1829
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Akagi, K., Ikeda, Y., Miyazaki, M. et al. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer 83, 887–891 (2000). https://doi.org/10.1054/bjoc.2000.1396
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2000.1396
Keywords
This article is cited by
-
An origami paper-based nanoformulated immunosensor detects picograms of VEGF-C per milliliter of blood
Communications Biology (2021)
-
HMGB1: an overview of its versatile roles in the pathogenesis of colorectal cancer
Cellular Oncology (2020)
-
Intestinal lymphatic vasculature: structure, mechanisms and functions
Nature Reviews Gastroenterology & Hepatology (2017)
-
The relevance of cell type- and tumor zone-specific VEGFR-2 activation in locally advanced colon cancer
Journal of Experimental & Clinical Cancer Research (2015)
-
Influence of Cancer-Associated Endometrial Stromal Cells on Hormone-Driven Endometrial Tumor Growth
Hormones and Cancer (2015)
